Cowealth Medical Holding Co Ltd (4745) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cowealth Medical Holding Co Ltd (4745) has a cash flow conversion efficiency ratio of -0.095x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-481.14 Million ≈ $-15.16 Million USD) by net assets (NT$5.06 Billion ≈ $159.31 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 4745 equity to assets ratio to measure how much of total assets are equity-financed.
Cowealth Medical Holding Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Cowealth Medical Holding Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Cowealth Medical Holding Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Cowealth Medical Holding Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cowealth Medical Holding Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GEE Group Inc
NYSE MKT:JOB
|
-0.024x |
|
Argent Minerals Ltd
AU:ARD
|
-0.260x |
|
Proximar Seafood AS
OL:PROXI
|
-0.204x |
|
Aasen Sparebank
OL:AASB
|
0.017x |
|
HAMILTON GLB.OPP.LS-0001
F:5DS
|
N/A |
|
Milae Bioresources Co. Ltd
KQ:218150
|
-0.011x |
|
Eupe Corporation Bhd
KLSE:6815
|
0.111x |
|
Haiwan International Development Co Ltd
TWO:3252
|
0.028x |
Annual Cash Flow Conversion Efficiency for Cowealth Medical Holding Co Ltd (2017–2025)
The table below shows the annual cash flow conversion efficiency of Cowealth Medical Holding Co Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see Cowealth Medical Holding Co Ltd (4745) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$5.06 Billion ≈ $159.31 Million |
NT$15.53 Million ≈ $489.28K |
0.003x | -96.60% |
| 2024-12-31 | NT$5.19 Billion ≈ $163.65 Million |
NT$469.43 Million ≈ $14.79 Million |
0.090x | +909.36% |
| 2023-12-31 | NT$5.03 Billion ≈ $158.42 Million |
NT$45.02 Million ≈ $1.42 Million |
0.009x | +117.41% |
| 2022-12-31 | NT$5.20 Billion ≈ $163.89 Million |
NT$-267.59 Million ≈ $-8.43 Million |
-0.051x | -53.18% |
| 2021-12-31 | NT$3.53 Billion ≈ $111.06 Million |
NT$-118.38 Million ≈ $-3.73 Million |
-0.034x | -114.32% |
| 2020-12-31 | NT$3.43 Billion ≈ $108.10 Million |
NT$804.75 Million ≈ $25.35 Million |
0.235x | +673.55% |
| 2019-12-31 | NT$3.34 Billion ≈ $105.38 Million |
NT$-136.78 Million ≈ $-4.31 Million |
-0.041x | -157.89% |
| 2018-12-31 | NT$1.89 Billion ≈ $59.60 Million |
NT$133.64 Million ≈ $4.21 Million |
0.071x | -13.07% |
| 2017-12-31 | NT$1.66 Billion ≈ $52.44 Million |
NT$135.26 Million ≈ $4.26 Million |
0.081x | -- |
About Cowealth Medical Holding Co Ltd
Cowealth Medical Holding Co., Ltd., together with its subsidiaries, engages in trading of medical equipment, reagents, and spare parts in Taiwan, China, and Hong Kong. It operates in two segments, Sells Equipment, and Sells Reagents and Others. The company also offers acme empowerment program, including al-assisted clinical decision support system, platform of management analysis and decision mak… Read more